Shubham99

1

• Coherent Market InsightsMarket Research and
  Business Consulting Serviceshttps//www.coheren
  tmarketinsights.com
• SINGLE-USE BIOPROCESSING SYSTEMS MARKET ANALYSIS

2
Single-use Bioprocessing Systems Market
Insights

• Single-use bioprocessing system is a disposable
  bioprocessing process in which the systems such
  as disposable bioreactor, single-use bags, and
  disposable filters are disposed after use instead
  of cleaning or sterilization. Single-use systems
  are majorly adapted in upstream and downstream
  bioprocessing, owing to its benefits over
  conventional bioprocessing systems, which
  includes reduction of cost, increased speed of
  implementation, and reduced risk of
  cross-contamination. Moreover, increasing
  adoption of single-use bioprocessing systems,
  increasing investment in research and development
  (RD) sector by various government and private
  organizations, increasing demand for single-use
  systems in biopharmaceutical sector and
  increasing number of key players offering
  technologically advanced bioprocessing products
  are projected to augment growth of the single-use
  bioprocessing systems market over the forecast
  period.
• The global single-use bioprocessing systems
  market was valued at US 2.80 billion in 2018,
  and is expected to witness a CAGR of 17.2 over
  the forecast period (2018 2026).

3
Fig Global Single-use Bioprocessing
Systems Market Share (), By Product Type

• Source Coherent Market Insights

4
Increasing Adoption of Single-Use Bioprocessing
Technologies is expected to Drive Growth of the
Single-use Bioprocessing Systems Market

• Increasing demand for biologics, need for
  production capacity expansion, patent expiry of
  blockbuster molecules, and a limited number of
  potential products in the pipeline have driven
  the companies to adopt new technologies such as
  single-use bioprocessing systems. Single-use
  equipment offers various benefits making
  biomanufacturing process more efficient and cost
  effective. Single-use technologies is a rapidly
  evolved and adopted owing to their ability to
  offer significant cost reduction, ease of
  disposable, time saving, less energy and water
  demand for bioprocessing process, reduced risk of
  contamination and increase in productivity.
  Moreover, single-use bioprocessing systems
  reduces the initial investments and research and
  development (RD) cost involved in the
  manufacturing of biologics and biopharmaceuticals.
  Conventional manufacturing of biopharmaceuticals
  and biologics involves use of stainless
  steel-based bioreactor and their subcomponents.
  Most of these products require sterilization and
  associated units for manufacturing
  contamination-free bio-products and biologics,
  which significantly increases overall investment
  cost. Moreover, according to the data published
  in Bioprocess International Journal in December
  2015, single-use bioprocessing systems eliminate
  additional investment cost, as sterilization is
  not required. This lower around 40 of investment
  costs compared to stainless steel facility.
• Furthermore, increasing research and development
  investment by various government and private
  organizations in therapeutic, biopharmaceutical,
  and clinical diagnostics area is expected to
  propel demand for efficient and cost-effective
  bioprocessing pilot study plants designed with
  single-use bioprocessing technologies. For
  instance, according to Farmaindustria the
  National Business Association of the
  Pharmaceutical Industry in Spain, pharmaceutical
  companies in Spain invested US 1,154.7 million
  in research and development activities in 2014.
  Among these total amount invested, more than half
  of the amount (US 591.9, 51.26) was allocated
  to fund clinical trials, which is the 63
  increase in investment over the last decade (2004
  to 2014).
• Furthermore, National Cancer Institute (NCI)
  invested US 749.8 million, US 769.2 million and
  US 801 million on cancer related clinical trials
  in 2014, 2015, and 2016, respectively. Moreover,
  according to the World Intellectual Property
  Indicators 2017 report, Asia (64.6) accounted to
  register highest percentage of patent
  applications for 2016, followed by North America
  (20.5), Europe (11.3), Latin America and the
  Caribbean (2), Oceania (1.1), and Africa
  (0.5). According to the same source, in 2016,
  China registered highest number of patents
  (1,338,503 patent applications), with 21.5
  annual growth. Moreover, increasing RD
  activities coupled with increasing adoption of
  disposable systems is expected to drive growth of
  single-use bioprocessing systems market.

5
Increasing Demand for Biopharmaceuticals is
Driving Growth of Single-use Bioprocessing
Systems Market

• Single-use bioprocessing systems are increasingly
  adopted by biopharmaceutical industry owing to
  their increased efficiency, low cost investment,
  and low maintenance, with significant time
  savings during bioprocessing process. For
  instance, according to the Office for National
  Statistics(ONS) 2014 Business Enterprise
  Research and Development data findings, in 2013,
  the pharmaceutical industry in U.K. accounted for
  22 of all research and development (RD)
  expenditure, investing around US 6.76 billion.
  According to The International Trade
  Administration (ITA), the U.S. accounted for the
  largest market for biopharmaceutical sector,
  accounting for 17 of all domestic research and
  development (RD) funded by U.S. private
  organizations, with added an estimated US 1.2
  trillion in economic output in 2014. Furthermore,
  according to the 14th Annual report and Survey of
  Biopharmaceutical Manufacturing report 2017,
  biopharmaceutical industry exhibit an overall
  consistent 14-15 industry growth. Moreover,
  increasing investment by various government
  organizations to boost the biopharmaceutical
  industry is expected to increase the demand for
  biopharmaceutical thereby accelerating demand
  for single-use bioprocessing systems in near
  future. For instance, in June 2017, Ministry of
  Science and Technology, India launched US 250
  million program to promote the production of
  biological drugs and thereby boost India's
  biopharmaceutical industry.
• However, extractability and leachability issues
  related to single-use bioprocessing systems is
  expected to hinder the growth of single-use
  bioprocessing systems market over the forecast
  period. Single-use systems bioreactors are more
  susceptible to problems associated with compound
  leaching into the bioprocessing fluid as compared
  to conventional stainless steel bioreactor.
  Leachables are any compounds, both organic or
  inorganic that migrate into drug product
  formulations from the container closure as a
  result of direct contact with the formulation.
  With the rapid expansion of single-use systems
  for bioprocessing, plastics-based bioprocessing
  reactors are extensively used in
  biopharmaceutical production. According to the
  data published in American Pharmaceutical Review
  Journal in December 2017, leachables from
  single-use bioprocessing assemblies can adversely
  affect cell culture performance. Furthermore,
  excessive quantities of leached bDtBPP were shown
  to be toxic to various array of cell lines.
  Moreover, evaluation of leachables to reduce
  patient safety risks is necessary during
  single-use bioprocessing.
• Key players operating in single-use bioprocessing
  systems market include Compagnie de Saint-Gobain
  S.A., Thermo Fisher Scientific Inc., Applikon
  Biotechnology BV, Parker-Hannifin Corporation,
  Sartorius AG, Eppendorf AG, Danaher Corporation,
  Merck KGaA, and General Electric Company.

6
Links

• Request Sample Report https//www.coherentmarketi
  nsights.com/insight/request-sample/1754
• Request Customization https//www.coherentmarketi
  nsights.com/insight/request-customization/1754
• Download PDF Brochure https//www.coherentmarketi
  nsights.com/insight/request-pdf/1754
• Talk to Analyst https//www.coherentmarketinsight
  s.com/insight/talk-to-analyst/1754
• Reference https//www.coherentmarketinsights.com/
  market-insight/single-use-bioprocessing-systems-ma
  rket-1754

7
About US

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

8
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

9
Thank You !

• Kindly follow CMI Social Media Profiles for the
  latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/